Yuichi Uwai

Dr. Yuichi Uwai


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Pharmacological Research
Verified
Journal Article
Closed access
YUYuichi Uwai
Yuichi Uwai
HHHiroaki Honjo
Hiroaki Honjo
KIKikuo Iwamoto
Kikuo Iwamoto

1 January 2011 in Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
YUYuichi Uwai
Yuichi Uwai
YOYukihiro Ozeki
Yukihiro Ozeki
TITomonori Isaka
Tomonori Isaka
HHHiroaki Honjo
Hiroaki Honjo
KIKikuo Iwamoto
Kikuo Iwamoto
Several kinds of food have been shown to influence the absorption and metabolism of drugs, although there is little information about their effect on the renal excretion of drugs. In this study, we performed uptake experiments using Xenopus laevis oocytes to assess the inhibitory effects of chlorogenic acid, caffeic acid and quinic acid, which are contained in coffee, fruits and vegetables, on human organic anion transporters hOAT1 and hOAT3; these transporters mediate renal tubular uptake of anionic drugs from blood. Injection of hOAT1 and hOAT3 cRNA into oocytes stimulated uptake of typical substrates of hOAT1 and hOAT3 (p-aminohippurate and estrone sulfate, respectively); among the three compounds tested, caffeic acid most strongly inhibited these transporters. The apparent 50% inhibitory concentrations of caffeic acid were estimated to be 16.6 µM for hOAT1 and 5.4 µM for hOAT3. Eadie-Hofstee plot analysis showed that caffeic acid inhibited both transporters in a competitive manner. In addition to the transport of p-aminohippurate and estrone sulfate, that of antifolates and antivirals was inhibited by caffeic acid. These findings show that caffeic acid has inhibitory potential against hOAT1 and hOAT3, suggesting that renal excretion of their substrates could be affected in patients consuming a diet including caffeic acid.

1 September 2014 in Pharmacological Research
Verified
Journal Article
Closed access
YUYuichi Uwai
Yuichi Uwai
RARyosuke Arima
Ryosuke Arima
CTChihiro Takatsu
Chihiro Takatsu
RFRyo Furuta
Ryo Furuta
TKTatsuya Kawasaki
Tatsuya Kawasaki
TNTomohiro Nabekura
Tomohiro Nabekura

10 November 2011 in Biopharmaceutics & Drug Disposition
Verified
Journal Article
Closed access
PDF file
HHHiroaki Honjo
Hiroaki Honjo
YUYuichi Uwai
Yuichi Uwai
YAYouhei Aoki
Youhei Aoki
KIKikuo Iwamoto
Kikuo Iwamoto

1 January 2010 in Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
YUYuichi Uwai
Yuichi Uwai
KIKikuo Iwamoto
Kikuo Iwamoto
The transport of antifolate aminopterin by human organic anion transporters hOAT1 (SLC22A6) and hOAT3 (SLC22A8) was characterized using Xenopus laevis oocytes and was compared with that of methotrexate. Although hOAT1 and hOAT3 transported both aminopterin and methotrexate, uptake of methotrexate was greater in hOAT3-expressing oocytes than in hOAT1-expressing oocytes, and aminopterin was transported by hOAT1 more efficiently. The apparent 50% inhibitory concentration (IC(50)) of aminopterin for p-aminohippurate uptake by hOAT1 was lower than that of methotrexate (methotrexate: 998 microM, aminopterin: 160 microM). On the other hand, IC(50) values of these antifolates for estrone sulfate transport by hOAT3 were comparable (methotrexate: 61.5 microM, aminopterin: 59.2 microM). The Michaelis-Menten constant and maximum velocity of aminopterin transport by hOAT1 were calculated to be 226 microM and 72.5 pmol/ oocyte/2 hr, respectively. Probenecid and non-steroidal anti-inflammatory drugs strongly inhibited the transport. These findings show that both aminopterin and methotrexate are substrates of hOAT1 and hOAT3, and that there are differences between the antifolates in terms of their transport characteristics.

22 November 2018 in Molecules
Verified
Journal Article
Open access
PDF file
YUYuichi Uwai
Yuichi Uwai
Drug transporters mediate the absorption, tissue distribution, and excretion of drugs. The cDNAs of P-glycoprotein, multidrug resistance proteins (MRPs/ABCC), breast cancer resistance protein (BCRP/ABCG2), peptide transporters (PEPTs/SLC15), proton-coupled folate transporters (PCFT/SLC46A1), organic anion transporting polypeptides (OATPs/SLCO), organic anion transporters (OATs/SLC22), organic cation transporters (OCTs/SLC22), and multidrug and toxin extrusions (MATEs/SLC47) have been isolated, and their functions have been elucidated. Enantioselectivity has been demonstrated in the pharmacokinetics and efficacy of drugs, and is important for elucidating the relationship with recognition of drugs by drug transporters from a chiral aspect. Enantioselectivity in the transport of drugs by drug transporters and the inhibitory effects of drugs on drug transporters has been summarized in this review.